Digestive Diseases and Sciences

, Volume 50, Issue 10, pp 1889–1897 | Cite as

Pharmacological Basis for the Medicinal Use of Ginger in Gastrointestinal Disorders

  • Muhammad Nabeel Ghayur
  • Anwarul Hassan GilaniEmail author


Ginger (rhizome of Zingiber officinale) has been widely used for centuries in gastrointestinal disorders, particularly dyspepsia, but its precise mode of action has yet to be elucidated. This study was undertaken to study the prokinetic action of ginger and its possible mechanism of action. Prokinetic activity of ginger extract (Zo.Cr) was confirmed in an in vivo test when it enhanced the intestinal travel of charcoal meal in mice. This propulsive effect of the extract, similar to that of carbachol, was blocked in atropine-pretreated mice, a standard cholinergic antagonist. Likewise, Zo.Cr showed an atropine-sensitive dose-dependent spasmogenic effect in vitro as well as in isolated rat and mouse stomach fundus tissues. In atropinized tissue, it showed spasmolytic activity as shown by the inhibition of 5-HT- and K+-induced contractions. A spasmolytic effect was also observed in other gut preparations either as noncompetitive inhibition of agonist dose–response curves, inhibition of high K+(80 mM)-induced contractions, or displacement of Ca2+ dose–response curves to the right, indicating a calcium antagonist effect. Phytochemical analysis revealed the presence of saponins, flavonoids, and alkaloids in the crude extract. These data indicate that Zo.Cr contains a cholinergic, spasmogenic component evident in stomach fundus preparations which provides a sound mechanistic insight for the prokinetic action of ginger. In addition, the presence of a spasmolytic constituent(s) of the calcium antagonist type may explain its use in hyperactive states of gut like colic and diarrhea.

Key Words

Zingiber officinale ginger prokinetic cholinergic calcium antagonist 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Langner E, Greifenberg S, Gruenwald J: Ginger: History and use. Adv Ther 15:25–44, 1998PubMedGoogle Scholar
  2. 2.
    Ghayur MN, Gilani AH: Ginger: from myths to reality. In Handbook of Ethnotherapies. CE Gottschalk, JC Green (eds). Hamburg, Verlag und Vertrieb, 2005 (in press)Google Scholar
  3. 3.
    Mascolo N, Jain R, Jain SC, Capasso F: Ethnopharmacologic investigation of ginger (Zingiber officinale). J Ethnopharmacol 27:129–140, 1989CrossRefPubMedGoogle Scholar
  4. 4.
    Ghayur MN, Gilani AH: Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol 45:74–80, 2005CrossRefPubMedGoogle Scholar
  5. 5.
    Connell DW, McLachlan R: Natural pungent compounds: examination of gingerols, shogaols, paradols and related compounds by thin-layer and gas chromatography. J Chromatogr 67:29–35, 1972CrossRefGoogle Scholar
  6. 6.
    Varma KR, Jain TC, Bhattacharyya SC: Structure and stereochemistry of zingiberol and Juniper camphor. Tetrahedron 18:979, 1962CrossRefGoogle Scholar
  7. 7.
    Nadkarni KM: Zingiber officinale. In Indian Materia Medica. Bombay, Popular Prakashan, 1976, pp 1308–1315Google Scholar
  8. 8.
    Yamahara J, Huang Q, Li L, Xu L, Fujimura H: Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem Pharm Bull 38:430–431, 1990PubMedGoogle Scholar
  9. 9.
    Qian DS, Liu ZS: Pharmacologic studies of antimotion sickness actions of ginger. Chung Kuo Chung His I Chieh Ho Tsa Chih 12:95–98, 1992Google Scholar
  10. 10.
    Mowrey DB, Clayson DE: Motion sickness, ginger, and psychophysics. Lancet 1:655–657, 1982CrossRefPubMedGoogle Scholar
  11. 11.
    Holtmann S, Clarke AH, Scherer H, Hohn M: The anti-motion sickness mechanism of ginger: a comparative study with placebo and dimenhydrinate. Acta Oto-Laryngol 108:168–174, 1989Google Scholar
  12. 12.
    Micklefield GH, Redeker Y, Meister V, Jung O, Greving I, May B: Effects of ginger on gastroduodenal motility. Int J Clin Pharmacol Ther 37:341–346, 1989Google Scholar
  13. 13.
    Sharma SS, Gupta YK: Reversal of cisplatin-induced delay in gastric emptying in rats by ginger. J Ethnopharmacol 62:49–55, 1998CrossRefPubMedGoogle Scholar
  14. 14.
    Stewart JJ, Wood MJ, Wood CD, Mims ME: Effects of ginger on motion sickness susceptibility and gastric function. Pharmacology 42:111–120, 1991PubMedGoogle Scholar
  15. 15.
    Phillips S, Hutchinson S, Ruggier R: Zingiber officinale does not affect gastric emptying rate. Anaesthesia 48:393–95, 1993PubMedGoogle Scholar
  16. 16.
    National Research Council: Guide for the Care and Use of Laboratory Animals. Washington, DC, National Academy Press, 1996, pp 1–7Google Scholar
  17. 17.
    Tona L, Kambu K, Ngimbi N, Cimanga K, Vlietinck AJ: Antiamoebic and phytochemical screening of some Congolese medicinal plants. J Ethnopharmacol 61:57–65, 1998CrossRefPubMedGoogle Scholar
  18. 18.
    Croci T, Landi M, Elmonds-Alt X, LeFur G, Maffrand JP, Manara L: Role of tachykinins in castor oil induced diarrhea in rats. Br J Pharmacol 121:375–380, 1997PubMedGoogle Scholar
  19. 19.
    Gilani AH, Cobbin LB: Interaction of himbacine with carbachol at muscarinic receptors of heart and smooth muscle. Arch Int Pharmacod Ther 290:46–53, 1987Google Scholar
  20. 20.
    Gilani AH, Aziz N, Khurram IM, Rao ZA, Ali NK: The presence of cholinomimetic and calcium channel antagonist constituents in Piper betle Linn. Phytother Res 14:436–442, 2000CrossRefPubMedGoogle Scholar
  21. 21.
    Gilani AH, Shaheen F, Christopoulos A, Mitchelson F: Interaction of ebeinone, an alkaloid from Fritillaria imperialis, at two muscarinic acetylcholine receptor subtypes. Life Sci 60:535–544, 1997CrossRefPubMedGoogle Scholar
  22. 22.
    Taylor P: Cholinergic agonists. In The Pharmacological Basis of Therapeutics. AG Gilman, LS Goodman, A Gilman (eds). New York, Macmillan, 1991, pp 122–130Google Scholar
  23. 23.
    Arunlakhshana O, Schild HO: Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58, 1959PubMedGoogle Scholar
  24. 24.
    Gilani AH, Cobbin LB: Cardioselectivity of himbacine: a muscarinic receptor antagonist. Naunyn-Schmiedeberg's Arch Pharmacol 332:16–20, 1986CrossRefGoogle Scholar
  25. 25.
    Brown JH, Taylor P: Muscarinic receptor agonists and antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics. JG Hardman, LE Limbird (eds). New York, McGraw–Hill, 1996, pp 141–160Google Scholar
  26. 26.
    Wien R, Mason DF, Edge ND, Langston GT: The ganglion blocking properties of homologous compounds in the methonium series. Br J Pharmacol 7:534–541, 1952Google Scholar
  27. 27.
    Kerr PM, Hillier K, Wallis RM, Garland CJ: Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human colon. Br J Pharmacol 115:1518–1524, 1995PubMedGoogle Scholar
  28. 28.
    Morisset J, Geoffrion L, Larose L, Lanoe J, Poirier GG: Distribution of muscarinic receptors in the digestive tract organs. Pharmacology 22:189–195, 1981PubMedGoogle Scholar
  29. 29.
    Johnson PJ, Bornstein JC, Yuan SY, Furness JB: Analysis of contribution of acetylcholine and tachykinins to neuro-neuronal transmission in motility reflexes in the guinea pig ileum. Br J Pharmacol 118:973–983, 1996PubMedGoogle Scholar
  30. 30.
    Kapoor LD: Zingiber officinale. In Handbook of Ayurvedic Medicinal Plants. Boca Raton, FL, CRC Press, 1990, pp 341–342Google Scholar
  31. 31.
    Tyler VE: Ginger. In The Honest Herbal, 3rd ed. New York, Pharmaceutical Products Press, 1993, pp 147–148Google Scholar
  32. 32.
    Akah PA, Oli AN, Enwerem NM, Gamaneil K: Preliminary studies on purgative effect of Carica papaya root extract. Fitoterapia 68:327–331, 1997Google Scholar
  33. 33.
    Gilani AH, Aziz N, Khan MA, Shaheen F, Jabeen Q, Siddiqui BS, Herzig JW: Ethnopharmacological evaluation of the anticonvulsant, sedative and antispasmodic activities of Lavandula stoechas L. J Ethnopharmacol 71:161–167, 2000CrossRefPubMedGoogle Scholar
  34. 34.
    Bolton TB: Mechanism of action of transmitters and other substances on smooth muscles. Physiol Rev 59:606–718, 1979PubMedGoogle Scholar
  35. 35.
    Hamilton TC, Weir SW, Weston AH: Comparison of the effect of BRL 34915 and verapamil on electrical and mechanical activity on rat portal vein. Br J Pharmacol 88:103–111, 1986PubMedGoogle Scholar
  36. 36.
    Kobayashi S, Kitazawa T, Somlyo AE, Somlyo AP: Cytosolic heparin inhibits muscarinic and α-adrenergic Ca++ release in smooth muscle. J Biol Chem 264:17997–18001, 1989PubMedGoogle Scholar
  37. 37.
    Brunton LL: Agents affecting gastrointestinal water flux and motility; emesis and antiemetics; bile acids and pancreatic enzymes. In Goodman and Gillman's The Pharmacological Basis of Therapeutics. JG Hardman, LE Limbird (eds). New York, McGraw–Hill, 1996, pp 917–936Google Scholar
  38. 38.
    Dicarlo G, Autore G, Izzo A, Maiolino P, Mascolo N, Viola P, Diurno MV, Capasso F: Inhibition of intestinal motility and secretion by flavonoids in mice and rats: structure activity relationships. J Pharm Pharmacol 45:1054–1059, 1993PubMedGoogle Scholar
  39. 39.
    Huang Q, Matsuda H, Sakai K, Yamahara J, Tamai Y: The effect of ginger on serotonin induced hypothermia and diarrhea. Yakugaku Zasshi 110:936–942, 1991Google Scholar
  40. 40.
    Eglen RM, Hedge SS, Watson N: Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48:531–565, 1996PubMedGoogle Scholar
  41. 41.
    Ghayur MN, Gilani AH: Gastrointestinal stimulatory and uterotonic activities of dietary radish leaves extract are mediated through multiple pathways Phytother Res 2005 (in press)Google Scholar
  42. 42.
    Pomfret DW, Schenck KW, Fludzinski P, Cohen ML: Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle. J Pharmacol Exp Ther 241:465–71, 1987PubMedGoogle Scholar
  43. 43.
    Ichida S, Oka H, Masada A, Fujisue T, Hata T, Matsuda N: Effects of synthetic omega-conotoxin on the contractile responses of segments of rat ileum, stomach fundus and uterus and guinea pig taenia coli. Jpn J Pharmacol 48:395–405, 1988PubMedGoogle Scholar
  44. 44.
    Gaion RM, Basadonna O, Santostasi G, Fantin M, Maragno I, Dorigo P: Antispasmodic effect of amiodarone on gastrointestinal smooth muscle: possible involvement of calcium. Arch Int Pharmacodyn Ther 294:112–124, 1988PubMedGoogle Scholar
  45. 45.
    Cocks TM, Angus JA: Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium–derived relaxing factor (EDRF), acidified sodium nitrite (NO) and sodium nitroprusside. Naunyn-Schmiedeberg's Arch Pharmacol 341:364–372, 1990CrossRefGoogle Scholar
  46. 46.
    Smaili SS, Carvalho SM, Cavalcanti PM, Jurkiewicz NH, Garcia AG, Jurkiewicz A: Intracellular calcium mobilization by muscarinic receptors is regulated by micromolar concentrations of external Ca+ +. Pflugers Arch 442:376–382, 2001CrossRefPubMedGoogle Scholar
  47. 47.
    Buharalioglu CK, Akar F: The reactivity of serotonin, acetylcholine and KCl-induced contractions to relaxant agents in the rat gastric fundus. Pharmacol Res 45:325–331, 2002CrossRefPubMedGoogle Scholar
  48. 48.
    Vanhoute PM: Differential effects of calcium entry blockers on vascular smooth muscle. In New Perspectives on Calcium Antagonists. GB Weis (Ed). Bethesda, MD, American Physiological Society, 1981, pp 109–121Google Scholar
  49. 49.
    Borrelli F, Capasso R, Pinto A, Izzo AA: Inhibitory effect of ginger (Zingiber officinale) on rat ileal motility in vitro. Life Sci 74:2889–2896, 2004CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Muhammad Nabeel Ghayur
    • 1
  • Anwarul Hassan Gilani
    • 1
    • 2
    Email author
  1. 1.Department of Biological and Biomedical SciencesThe Aga Khan University Medical CollegeKarachiPakistan
  2. 2.Department and SciencesThe Aga Khan University Medical CollegeKarachiPakistan

Personalised recommendations